Clinical management of psychostimulant withdrawal: review of the evidence.
Li MJ, Shoptaw SJ.
Addiction. 2023 Apr;118(4):750-762. doi: 10.1111/add.16093. Epub 2022 Dec 12.
Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.
Kitanaka J, Kitanaka N, Takemura M.
Neurochem Res. 2008 Jan;33(1):204-19. doi: 10.1007/s11064-007-9409-7. Epub 2007 Jun 29.
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ, Lee SY.
Curr Obes Rep. 2021 Mar;10(1):14-30. doi: 10.1007/s13679-020-00422-w. Epub 2021 Jan 6.
Treatment for amphetamine withdrawal.
Shoptaw SJ, Kao U, Heinzerling K, Ling W.
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003021. doi: 10.1002/14651858.CD003021.pub2.
Understanding the Mechanisms of Action and Effects of Drugs of Abuse.
Ciucă Anghel DM, Nițescu GV, Tiron AT, Guțu CM, Baconi DL.
Molecules. 2023 Jun 24;28(13):4969. doi: 10.3390/molecules28134969.
Understanding Stimulant Use and Use Disorders in a New Era.
Ciccarone D, Shoptaw S.
Med Clin North Am. 2022 Jan;106(1):81-97. doi: 10.1016/j.mcna.2021.08.010.
Stimulant withdrawal.
Lago JA, Kosten TR.
Addiction. 1994 Nov;89(11):1477-81. doi: 10.1111/j.1360-0443.1994.tb03746.x.
Treatment for amphetamine withdrawal.
Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P.
Cochrane Database Syst Rev. 2001;(4):CD003021. doi: 10.1002/14651858.CD003021.
Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.
Bray B, Scholl JL, Tu W, Watt MJ, Renner KJ, Forster GL.
Brain Res. 2016 Aug 1;1644:278-87. doi: 10.1016/j.brainres.2016.05.030. Epub 2016 May 18.
Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion.
Watson R, Hartmann E, Schildkraut JJ.
Am J Psychiatry. 1972 Sep;129(3):263-9. doi: 10.1176/ajp.129.3.263.
